Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene is an intermediate used to prepare retinoid X receptor (RXR) antagonists of orally active anti-diabetic and anti-obesity agents.